576 related articles for article (PubMed ID: 10454682)
1. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
[TBL] [Abstract][Full Text] [Related]
2. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
Marina NM; Cushing B; Giller R; Cohen L; Lauer SJ; Ablin A; Weetman R; Cullen J; Rogers P; Vinocur C; Stolar C; Rescorla F; Hawkins E; Heifetz S; Rao PV; Krailo M; Castleberry RP
J Clin Oncol; 1999 Jul; 17(7):2137-43. PubMed ID: 10561269
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and prognostic study of pediatric immature teratoma].
Yang WP; Zou Y; Huang CS; Zhang SZ; Xiao Q; Dai KL; Zhong HS; Xiong XJ
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):666-71. PubMed ID: 18194599
[TBL] [Abstract][Full Text] [Related]
4. Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study.
Hawkins E; Issacs H; Cushing B; Rogers P
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):406-9. PubMed ID: 7692755
[TBL] [Abstract][Full Text] [Related]
5. Sacrococcygeal yolk sac tumor developing after teratoma: a clinicopathological study of pediatric sacrococcygeal germ cell tumors and a proposal of the pathogenesis of sacrococcygeal yolk sac tumors.
Yoshida M; Matsuoka K; Nakazawa A; Yoshida M; Inoue T; Kishimoto H; Nakayama M; Takaba E; Hamazaki M; Yokoyama S; Horie H; Tanaka M; Gomi K; Ohama Y; Kigasawa H; Kitano Y; Uchida H; Kanamori Y; Iwanaka T; Tanaka Y
J Pediatr Surg; 2013 Apr; 48(4):776-81. PubMed ID: 23583133
[TBL] [Abstract][Full Text] [Related]
6. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
8. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
[TBL] [Abstract][Full Text] [Related]
9. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.
Pashankar F; Hale JP; Dang H; Krailo M; Brady WE; Rodriguez-Galindo C; Nicholson JC; Murray MJ; Bilmire DF; Stoneham S; Arul GS; Olson TA; Stark D; Shaikh F; Amatruda JF; Covens A; Gershenson DM; Frazier AL
Cancer; 2016 Jan; 122(2):230-7. PubMed ID: 26485622
[TBL] [Abstract][Full Text] [Related]
10. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases.
Mitchell PL; Al-Nasiri N; A'Hern R; Fisher C; Horwich A; Pinkerton CR; Shepherd JH; Gallagher C; Slevin M; Harper P; Osborne R; Mansi J; Oliver T; Gore ME
Cancer; 1999 May; 85(10):2232-44. PubMed ID: 10326703
[TBL] [Abstract][Full Text] [Related]
12. Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group.
Heifetz SA; Cushing B; Giller R; Shuster JJ; Stolar CJ; Vinocur CD; Hawkins EP
Am J Surg Pathol; 1998 Sep; 22(9):1115-24. PubMed ID: 9737245
[TBL] [Abstract][Full Text] [Related]
13. Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience.
Mann JR; Gray ES; Thornton C; Raafat F; Robinson K; Collins GS; Gornall P; Huddart SN; Hale JP; Oakhill A;
J Clin Oncol; 2008 Jul; 26(21):3590-7. PubMed ID: 18541896
[TBL] [Abstract][Full Text] [Related]
14. Ovarian Yolk Sac Tumors; Does Age Matter?
Faure Conter C; Xia C; Gershenson D; Hurteau J; Covens A; Pashankar F; Krailo M; Billmire D; Patte C; Fresneau B; Shaikh F; Stoneham S; Nicholson J; Murray M; Frazier AL
Int J Gynecol Cancer; 2018 Jan; 28(1):77-84. PubMed ID: 29194189
[TBL] [Abstract][Full Text] [Related]
15. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mixed germ cell tumor composed of endodermal sinus tumor and immature teratoma: case report.
Ohara N; Teramoto K
Clin Exp Obstet Gynecol; 2000; 27(2):95-6. PubMed ID: 10968342
[No Abstract] [Full Text] [Related]
17. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.
Göbel U; Calaminus G; Schneider DT; Koch S; Teske C; Harms D
Klin Padiatr; 2006; 218(6):309-14. PubMed ID: 17080332
[TBL] [Abstract][Full Text] [Related]
18. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.
Newton C; Murali K; Ahmad A; Hockings H; Graham R; Liberale V; Sarker SJ; Ledermann J; Berney DM; Shamash J; Banerjee S; Stoneham S; Lockley M
Eur J Cancer; 2019 May; 113():19-27. PubMed ID: 30954883
[TBL] [Abstract][Full Text] [Related]
19. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
[TBL] [Abstract][Full Text] [Related]
20. Ovarian mixed germ cell tumor with predominance of polyembryoma: a case report with literature review.
Jondle DM; Shahin MS; Sorosky J; Benda JA
Int J Gynecol Pathol; 2002 Jan; 21(1):78-81. PubMed ID: 11781529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
